PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS, page-117

  1. 9,801 Posts.
    lightbulb Created with Sketch. 1243
    They already have 1.5mg/kg x 2 in the Stage 1 protocol.

    This may end up being replaced with 2mg/kg x 2 given safety concerns over rat studies has been comprehensively dealt with since.

    Remember the DMC will decide the final dosage protocol to be used for OA002 based on statistical significance of Stage 1 protocols. Interim results of Stage 1 are suggesting they will be accommodating to this request to revise the dosage protocols back to the preferred 2mg/kg. This optimal dosage is supported by all historical studies as being statistically significant with clinical meaningful effect size per (008, SAS, 2B, NFL etc). The chance of 2mg/kg x 2 not repeating the same or equivalent results are less than extremely remote. Those looking at the actual data will understand this point better than most of us on here.






 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.